HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis.
Pu-Chun LiYi-Fan ZhuJia-Ni PanQiao-Yan ZhuYu-Yang LiaoXiao-Wen DingLin-Feng ZhengWen-Ming CaoPublished in: Therapeutic advances in medical oncology (2024)
mutations have no significant effect on the survival of Chinese women with HR-positive/HER2-negative breast cancer.